Airway and alveolar nitric oxide production, lung function, and pulmonary blood flow in sickle cell disease

Alan Lunt1,2, Na'eem Ahmed1, Gerrard F Rafferty1

  • 1Division of Asthma, Allergy and Lung Biology, MRC Centre for Allergic Mechanisms in Asthma, King's College London, London, UK.

Pediatric Research
|October 23, 2015
PubMed

Insights

Children with sickle cell disease (SCD) show airway obstruction not linked to asthma. Increased alveolar nitric oxide (NO) production and pulmonary blood flow, not airway NO, were observed in SCD patients.

Area of Science:

  • Pediatric Pulmonology
  • Hematology
  • Biomedical Engineering

Background:

  • Children with sickle cell disease (SCD) frequently exhibit obstructive lung function abnormalities.
  • These abnormalities may stem from asthma or increased pulmonary blood volume, necessitating accurate diagnosis for effective treatment.
  • Exhaled nitric oxide (FeNO) is elevated in asthma but can also increase due to alveolar production, complicating its interpretation in SCD.

Purpose of the Study:

  • To investigate differences in airway and alveolar nitric oxide (NO) production between children with SCD and healthy controls.
  • To determine the underlying mechanisms of lung function abnormalities in pediatric SCD patients.
  • To differentiate between asthma-related and other causes of airway obstruction in SCD.

Main Methods:

  • Assessed lung function, including respiratory system resistance.
  • Measured airway NO flux and alveolar NO production.
  • Quantified effective pulmonary blood flow in 18 SCD children and 18 matched controls.

Main Results:

  • SCD children demonstrated significantly higher respiratory system resistance, alveolar NO production, and pulmonary blood flow compared to controls.
  • No significant difference in airway NO flux was found between SCD children and controls.
  • In SCD children, alveolar NO production and concentration correlated with pulmonary blood flow.

Conclusions:

  • Elevated airway NO flux was not observed in SCD children, and it did not correlate with airway obstruction.
  • These findings suggest that airway obstruction in some SCD children may not be primarily due to asthma.
  • Increased alveolar NO production and pulmonary blood flow are key features of lung dysfunction in pediatric SCD.
Abstract

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
6.8K